Single dose of psilocybin leads to decreased demoralisation and improved spiritual wellbeing among cancer sufferers, long-term research indicates.
Source: The Independent
Two studies published Thursday in the Journal of Psychopharmacology suggest that psilocybin may offer a dramatic helping hand.
Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy, appears to be associated with significant improvements in emotional and existential distress in people with cancer
Source: NYU Langone
Objectives of this learning scenario, developed by NYU Langone’s High School Bioethics Project, are to understand post-traumatic stress disorder (PTSD) and the symptoms it causes, learn how the chemical psilocybin, found in psychedelic drugs, can potentially help people who have PTSD, and discuss the ethical implications of using drugs that are often used recreationally as therapeutics.
Source: NYU Med